Cargando…

At the crossroads of epidemiology and biology: Bridging the gap between SARS-CoV-2 viral strain properties and epidemic wave characteristics

The COVID-19 pandemic has given rise to numerous articles from different scientific fields (epidemiology, virology, immunology, airflow physics …) without any effort to link these different insights. In this review, we aim to establish relationships between epidemiological data and the characteristi...

Descripción completa

Detalles Bibliográficos
Autores principales: Poydenot, Florian, Lebreton, Alice, Haiech, Jacques, Andreotti, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017177/
https://www.ncbi.nlm.nih.gov/pubmed/36931337
http://dx.doi.org/10.1016/j.biochi.2023.03.006
_version_ 1784907524422500352
author Poydenot, Florian
Lebreton, Alice
Haiech, Jacques
Andreotti, Bruno
author_facet Poydenot, Florian
Lebreton, Alice
Haiech, Jacques
Andreotti, Bruno
author_sort Poydenot, Florian
collection PubMed
description The COVID-19 pandemic has given rise to numerous articles from different scientific fields (epidemiology, virology, immunology, airflow physics …) without any effort to link these different insights. In this review, we aim to establish relationships between epidemiological data and the characteristics of the virus strain responsible for the epidemic wave concerned. We have carried out this study on the Wuhan, Alpha, Delta and Omicron strains allowing us to illustrate the evolution of the relationships we have highlighted according to these different viral strains. We addressed the following questions. 1) How can the mean infectious dose (one quantum, by definition in epidemiology) be measured and expressed as an amount of viral RNA molecules (in genome units, GU) or as a number of replicative viral particles (in plaque-forming units, PFU)? 2) How many infectious quanta are exhaled by an infected person per unit of time? 3) How many infectious quanta are exhaled, on average, integrated over the whole contagious period? 4) How do these quantities relate to the epidemic reproduction rate R as measured in epidemiology, and to the viral load, as measured by molecular biological methods? 5) How has the infectious dose evolved with the different strains of SARS-CoV-2? We make use of state-of-the-art modelling, reviewed and explained in the appendix of the article (Supplemental Information, SI), to answer these questions using data from the literature in both epidemiology and virology. We have considered the modification of these relationships according to the vaccination status of the population.
format Online
Article
Text
id pubmed-10017177
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM).
record_format MEDLINE/PubMed
spelling pubmed-100171772023-03-16 At the crossroads of epidemiology and biology: Bridging the gap between SARS-CoV-2 viral strain properties and epidemic wave characteristics Poydenot, Florian Lebreton, Alice Haiech, Jacques Andreotti, Bruno Biochimie Article The COVID-19 pandemic has given rise to numerous articles from different scientific fields (epidemiology, virology, immunology, airflow physics …) without any effort to link these different insights. In this review, we aim to establish relationships between epidemiological data and the characteristics of the virus strain responsible for the epidemic wave concerned. We have carried out this study on the Wuhan, Alpha, Delta and Omicron strains allowing us to illustrate the evolution of the relationships we have highlighted according to these different viral strains. We addressed the following questions. 1) How can the mean infectious dose (one quantum, by definition in epidemiology) be measured and expressed as an amount of viral RNA molecules (in genome units, GU) or as a number of replicative viral particles (in plaque-forming units, PFU)? 2) How many infectious quanta are exhaled by an infected person per unit of time? 3) How many infectious quanta are exhaled, on average, integrated over the whole contagious period? 4) How do these quantities relate to the epidemic reproduction rate R as measured in epidemiology, and to the viral load, as measured by molecular biological methods? 5) How has the infectious dose evolved with the different strains of SARS-CoV-2? We make use of state-of-the-art modelling, reviewed and explained in the appendix of the article (Supplemental Information, SI), to answer these questions using data from the literature in both epidemiology and virology. We have considered the modification of these relationships according to the vaccination status of the population. Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). 2023-10 2023-03-16 /pmc/articles/PMC10017177/ /pubmed/36931337 http://dx.doi.org/10.1016/j.biochi.2023.03.006 Text en © 2023 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Poydenot, Florian
Lebreton, Alice
Haiech, Jacques
Andreotti, Bruno
At the crossroads of epidemiology and biology: Bridging the gap between SARS-CoV-2 viral strain properties and epidemic wave characteristics
title At the crossroads of epidemiology and biology: Bridging the gap between SARS-CoV-2 viral strain properties and epidemic wave characteristics
title_full At the crossroads of epidemiology and biology: Bridging the gap between SARS-CoV-2 viral strain properties and epidemic wave characteristics
title_fullStr At the crossroads of epidemiology and biology: Bridging the gap between SARS-CoV-2 viral strain properties and epidemic wave characteristics
title_full_unstemmed At the crossroads of epidemiology and biology: Bridging the gap between SARS-CoV-2 viral strain properties and epidemic wave characteristics
title_short At the crossroads of epidemiology and biology: Bridging the gap between SARS-CoV-2 viral strain properties and epidemic wave characteristics
title_sort at the crossroads of epidemiology and biology: bridging the gap between sars-cov-2 viral strain properties and epidemic wave characteristics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017177/
https://www.ncbi.nlm.nih.gov/pubmed/36931337
http://dx.doi.org/10.1016/j.biochi.2023.03.006
work_keys_str_mv AT poydenotflorian atthecrossroadsofepidemiologyandbiologybridgingthegapbetweensarscov2viralstrainpropertiesandepidemicwavecharacteristics
AT lebretonalice atthecrossroadsofepidemiologyandbiologybridgingthegapbetweensarscov2viralstrainpropertiesandepidemicwavecharacteristics
AT haiechjacques atthecrossroadsofepidemiologyandbiologybridgingthegapbetweensarscov2viralstrainpropertiesandepidemicwavecharacteristics
AT andreottibruno atthecrossroadsofepidemiologyandbiologybridgingthegapbetweensarscov2viralstrainpropertiesandepidemicwavecharacteristics